We reposting an article of Monday about post-marketing surveillance for biosimilars.

#Biosimilars #Pharmacovigilance #ClinicalResearch #RealWorldEvidence #CDSCO #Pharma #CRO #ClinicalTrials

https://genelifecr.blogspot.com/2026/05/post-marketing-surveillance-for.html

Reposting our article on the #CDSCO approval process for #ClinicalTrials. As India continues to strengthen its #ClinicalResearch ecosystem, understanding the #Regulatory process is more important than ever.

https://genelifecr.blogspot.com/2026/04/cdsco-approval-process-for-clinical.html

Biosimilar approval is not the finish line.
It's the point at which your pre-approval dataset — intentionally smaller than a novel biologic — meets real patients, real clinical practice, and real immune systems.

PMS isn't overhead. It's the second half of your evidence strategy.

#Biosimilars #Pharmacovigilance #ClinicalResearch #Pharma #CRO #CDSCO #ClinicalTrials #genelife

https://genelifecr.blogspot.com/2026/05/post-marketing-surveillance-for.html

We published an article on Monday about India's biosimilar regulatory framework.

We are reposting the article again, in case you missed that:

#Biosimilars #ClinicalResearch #CRO #Pharma #Biologics #DrugDevelopment #CDSCO #RegulatoryAffairs #Pharmacovigilance #RWE

https://genelifecr.blogspot.com/2026/05/biosimilar-regulation-in-india-evolving.html

Our latest article explores the changing regulatory framework for biosimilars in India.

As the industry moves toward a more science-driven and risk-based approach, understanding the evolving biosimilar ecosystem becomes increasingly important for sponsors, researchers, and healthcare stakeholders.

#Biosimilars #ClinicalResearch #CRO #Pharma #Biologics #DrugDevelopment #CDSCO #RegulatoryAffairs #Pharmacovigilance #RWE

https://genelifecr.blogspot.com/2026/05/biosimilar-regulation-in-india-evolving.html

Explore the evolution of Indian Regulation

#ClinicalResearch #clinicaltrials #clinicalresearchindia #CDSCO #regulatoryaffairs #pharmaceuticalindustry
#DrugDevelopmentt #ndctr2019 #ICHGCP #IndiaPharma #ClinicalTrialRegulation
#GeneLife

https://genelifecr.blogspot.com/2026/04/history-and-evolution-of-clinical.html

India’s drug approval system is becoming faster, safer, and more efficient
CDSCO reforms are driving transparency, quality, and growth in the healthcare sector.

#CDSCO #PharmaSector #DrugRegulation #HealthMinistry #CurrentAffairs #Vidyakasam #CompetitiveExams #IndiaProgress